Zivo Bioscience Inc

Strome’s $2‑share purchase of Zivo Bioscience fuels insider buying and a social‑media buzz, hinting at a potential rebound for the algae‑derived tech company.

Insider buys at Zivo Bioscience signal confidence in its algal‑based platform amid volatile valuations, offering high‑risk, high‑reward potential.

Insider buying at Zivo Bioscience shows confidence amid bearish trends. Discover how Maggiore’s $8.49 purchase may signal hidden value in algae‑based tech.

Insider buying at Zivo Bioscience signals confidence in its algae‑derived ingredients; insiders now own ~40% of float, hinting at potential upside amid low valuation.